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Cisplatin is an inorganic platinum agent (cis-diammine-
dichloroplatinum) with antineoplastic activity. It’sb e e n
an important component of standard treatment regi-
mens for several human malignancies including bladder
cancer [1]. Cisplatin forms highly reactive, charged, pla-
tinum complexes which bind to nucleophilic groups
such as GC-rich sites in DNA, inducing intrastrand and
interstrand DNA cross-links, as well as DNA-protein
cross-links. These cross-links result in apoptosis and cell
growth inhibition [2]. We have studied the cisplatin
induced apoptotic responses of one human urinary blad-
der cancer cell line 5637. The cytotoxic activity of cis-
platin on the survival profiles of 5637 cell line was
determined by MTT assay. The survival rates of 5637
c e l l si nt h ep r e s e n c eo f1 ,2 ,3 ,4 ,a n d5μg/ml cisplatin
after 72h of exposure were averaged 82.6, 55.4, 18.6, 7.2
and 7.9%, respectively. Treatment with cisplatin mark-
edly decreased the viability of 5637 cells in a dose-
dependent manner and a significant correlation was
found between cell proliferation and cisplatin concentra-
tion (r = 0.964; p < 0.01).
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